Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma
Clinical trial NCT01055522 · TERMINATED
Trial details
- NCT number
- NCT01055522
- Sponsor
- Philogen S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.